These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30008076)

  • 1. Preliminary experience with tigecycline treatment for severe infection in children.
    Ye S; Zhang C; Lin S
    Eur J Pediatr; 2018 Oct; 177(10):1489-1496. PubMed ID: 30008076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary experience of tigecycline treatment for infection in children with hematologic malignancies.
    Lin S; Zhang C; Ye S
    Int J Clin Pharm; 2018 Oct; 40(5):1030-1036. PubMed ID: 30051224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of tigecycline in treatment of pneumonia caused by MDR Acinetobacter baumannii: a systematic review and meta-analysis.
    Mei H; Yang T; Wang J; Wang R; Cai Y
    J Antimicrob Chemother; 2019 Dec; 74(12):3423-3431. PubMed ID: 31377765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tigecycline treatment experience against multidrug-resistant Acinetobacter baumannii infections: a systematic review and meta-analysis.
    Ni W; Han Y; Zhao J; Wei C; Cui J; Wang R; Liu Y
    Int J Antimicrob Agents; 2016 Feb; 47(2):107-16. PubMed ID: 26742726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii.
    Zhou Y; Chen X; Xu P; Zhu Y; Wang K; Xiang D; Wang F; Banh HL
    BMC Pharmacol Toxicol; 2019 Apr; 20(1):19. PubMed ID: 31023357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of extensively drug-resistant
    Guo W; Guo SC; Li M; Li LH; Qu Y
    Antimicrob Resist Infect Control; 2018; 7():22. PubMed ID: 29456841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tigecycline salvage therapy for critically ill children with multidrug-resistant/extensively drug-resistant infections after surgery.
    Song Y; Hu L; Shu Q; Ye J; Liang J; Chen X; Tan L
    Int J Infect Dis; 2018 Oct; 75():82-88. PubMed ID: 30125690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients.
    Kim WY; Moon JY; Huh JW; Choi SH; Lim CM; Koh Y; Chong YP; Hong SB
    PLoS One; 2016; 11(3):e0150642. PubMed ID: 26934182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case Report of Successful Treatment of Extensively Drug-Resistant Acinetobacter baumannii Ventriculitis with Intravenous plus Intraventricular Tigecycline.
    Liu Y; Pu Z; Zhao M
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104281
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged and high dosage of tigecycline - successful treatment of spondylodiscitis caused by multidrug-resistant Acinetobacter baumannii: a case report.
    Tsachouridou O; Georgiou A; Nanoudis S; Chrysanthidis T; Loli G; Morfesis P; Zebekakis P; Metallidis S
    J Med Case Rep; 2017 Jul; 11(1):186. PubMed ID: 28687078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is tigecyclin a good choice in the treatment of multidrug-resistant Acinetobacter baumannii pneumonia?
    Tasbakan MS; Pullukcu H; Sipahi OR; Tasbakan MI; Aydemir S; Bacakoglu F
    J Chemother; 2011 Dec; 23(6):345-9. PubMed ID: 22233818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
    Navon-Venezia S; Leavitt A; Carmeli Y
    J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
    Ye JJ; Lin HS; Yeh CF; Wu YM; Huang PY; Yang CC; Huang CT; Lee MH
    BMC Infect Dis; 2016 Aug; 16():374. PubMed ID: 27496018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
    Schafer JJ; Goff DA; Stevenson KB; Mangino JE
    Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of tigecycline shows that it may be an option for children with severe infections.
    Zhu ZY; Yang JF; Ni YH; Ye WF; Wang J; Wu ML
    Acta Paediatr; 2016 Oct; 105(10):e480-4. PubMed ID: 27381360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii.
    Ni W; Cui J; Liang B; Cai Y; Bai N; Cai X; Wang R
    J Antibiot (Tokyo); 2013 Dec; 66(12):705-8. PubMed ID: 23981963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of tigecycline in the treatment of infections caused by carbapenem-resistant gram-negative bacteria in pediatric liver transplant recipients: A retrospective study.
    Chen F; Shen C; Pang X; Zhang Z; Deng Y; Han L; Chen X; Zhang J; Xia Q; Qian Y
    Transpl Infect Dis; 2020 Feb; 22(1):e13199. PubMed ID: 31627248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical study on the safety and efficacy of high-dose tigecycline in the elderly patients with multidrug-resistant bacterial infections: A retrospective analysis.
    Xia G; Jiang R
    Medicine (Baltimore); 2020 Mar; 99(10):e19466. PubMed ID: 32150105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.